The in vitro susceptibility of Planctomycetes organisms to antibiotics has seldom been studied and when it has, a variety of methods have been used. The objective of the study was to expand the knowledge of Planctomycetes antibiotic susceptibility patterns.
Introduction
The phylum Planctomycetes is composed of environmental microorganisms characterized by budding reproduction, a peptidoglycan-less cell wall and cell compartmentation. 1 It is phylogenetically closely related to Verrucomicrobia and Chlamydiae, which accommodate major human and veterinary pathogens, and is combined with them in the so-called PVC superphylum. 1 Knowledge of antibiotic resistance in Planctomycetes may therefore elucidate that in PVC organisms at large. The peptidoglycan-less characteristic of Planctomycetes bacteria explains a natural resistance to peptidoglycan synthesis inhibitors, including b-lactams, glycopeptides and D-cycloserine. 2, 3 The incorporation of the latter antibiotics in primary culture media has assisted in the isolation of Planctomycetes organisms from contaminated specimens. 4 -6 However, few studies have been published regarding the in vitro susceptibility of Planctomycetes organisms to antibiotics. 2, 6, 7 The existing studies included relatively few antibiotics and Planctomycetes organisms. Additionally, testing methods were not standardized, being based on the antibiotic disc diffusion method, 6 on the agar microdilution method 7 or on macrodilution with direct observation of turbidity. 7 In an effort to increase our knowledge of Planctomycetes antibiotic susceptibility, we determined the susceptibility of representatives of the Planctomycetes phylum to 11 antibiotic families using the standardized Etest method. 
Methods

Strains and culture
Antimicrobial susceptibility testing
A plate of appropriate medium (half-strength marine agar or Caulobacter agar) was flooded using 3 mL of a 2.5+0.2 MacFarland unit suspension of bacteria; the excess suspension was removed and the plate was dried at room temperature for 5 min under the air flow of a microbiological safety cabinet. An Etest strip (Biomérieux, Craponne, France) was deposited on the surface of the agar medium using sterile forceps. The plate was then incubated at 308C and growth was observed after incubating for 7 days (except P. limnophilus, which was observed after incubating for 14 days). All tests were done in duplicate. A total of 18 antibiotics representing 11 antibiotic families were tested (Table 1) . One clinical isolate of each of Staphylococcus aureus, Enterococcus faecalis and Escherichia coli with known antimicrobial susceptibility patterns were used as controls on plates of both media incubated for 1 day at 308C to ensure the activity of Etest antibiotics. When S. aureus and E. faecalis strains were both susceptible to the same antibiotic (vancomycin and teicoplanin), we used the most susceptible strain as a control (S. aureus was used to test vancomycin and E. faecalis to test teicoplanin). A Nikon TMS inverted phase-contrast microscope with objective E.10 0.25 160/-(Nikon France S. A. S., Champigny Sur Marne, France) was used (100× magnification) to read the limit of growth inhibition. The presence of b-lactamase was tested twice with the cefinase test following the supplier's instructions (Becton-Dickinson, Le Pont de Claix, France). A b-lactamase-producing Haemophilus influenzae isolate was used as a positive control.
Results and discussion
The limit of growth inhibition around the Etest strip was difficult to determine by the naked eye for B. marina and P. maris. Etest reading was therefore performed using an inverted microscope for these two strains. For antibiotic susceptibility controls, we observed no MIC variation for E. coli, E. faecalis or S. aureus on either set of medium.
We observed that Planctomycetes were resistant to b-lactams and glycopeptides, a feature previously linked to the absence of peptidoglycan in their cell wall (Table 1) .
2,3,7 Accordingly, we found that Planctomycetes lacked a b-lactamase in the presence of a positive control. These data agree with our observation that Pirellula staleyi and R. baltica genomes lack genes coding for essential peptidoglycan synthesis and lysis enzymes, i.e. glycosyltransferase (GT) 28 including murG, GT 51 including peptidoglycan glycosyltransferase, glycoside hydrolase (GH) 23 including lytic transglycosylases and GH 73. Candidatus Kuenenia and the Chlamydia genomes encode only one enzyme of the GT 28 family (C. Cayrou, M. Drancourt and B. Henrissat, unpublished data).
Most Planctomycetes organisms were resistant to chloramphenicol and to the aminoglycoside gentamicin, targeting the 23S and the 16S rRNA of the 50S ribosomal subunit, respectively, and to rifampicin, a bacterial RNA polymerase inhibitor (Table 1) . 8 Rifampicin resistance has been primarily associated with mutations in the rpoB gene encoding the RNA polymerase b-subunit, reducing the affinity of the drug to the target. 9 At least three other bacterial phyla include organisms naturally resistant to rifampicin, without phylogenetic relationships between these phyla (Figure 1) . In Planctomycetes, the mechanism of resistance for these antibiotics is not elucidated. For chloramphenicol, we were unable to find any chloramphenicolinactivating enzyme usually associated with resistance encoded by bacterial genomes. However, we observed that Planctomycetes genomes encode numerous efflux pumps: the P. staleyi genome (GenBank accession number NC_013720) has six such genes that encode proteins homologous with those involved in multidrug resistance or that belong to a gene family referenced as 'resistance factor'; and the R. baltica genome (GenBank accession number NC_005027) has 20 efflux pump genes.
We observed a variable resistance to the sulfamethoxazole/trimethoprim association (Table 1 ). Sulfamethoxazole and trimethoprim inhibit DNA synthesis by inhibiting dihydropteroate synthase encoded by the folP gene and dihydrofolate reductase encoded by the folA gene. We observed that five Planctomycetes genomes (GenBank NC_005027, NZ_ABUK00000000, NZ_ABGO00000000, NZ_ABCE00000000 and NZ_AANZ00000000) encode the folP gene, but only the B. marina and R. baltica genomes encode folA. These two strains were susceptible to sulfamethoxazole/trimethoprim, whereas P. maris, G. obscuriglobus and P. limnophilus were resistant, suggesting that absence of the folA gene may explain the sulfamethoxazole/trimethoprim resistance in the latter organisms. We observed an important variability in the antibiotic susceptibility pattern between organisms belonging to the same genus (Table 1) . For the genus Planctomyces, we observed that P. brasiliensis was resistant to all antibiotics except for cyclins, whereas P. limnophilus was susceptible to eight antibiotics.
In this study, the Etest method was used for the first time to test the in vitro susceptibility of organisms in the phylum Planctomycetes to various antibiotics. We used the largest panel of antibiotic families and molecules ever tested on Planctomycetes organisms in a single study. The scope of the study allowed for the first in-depth depiction of the spectrum of antibiotic susceptibility, resistance and variation among Planctomycetes genera (Table 1 ). The Etest method was easy to use, because MIC values were directly observed without the need for further calculation and without the need for any apparatus other than an inverted microscope. Inverted microscopy allowed for the precise observation of growth limits. In addition, the Etest method required a minimum of manipulations.
Knowledge of the susceptibility pattern of Planctomycetes bacteria could help improve the rational composition of culture media. Indeed, some samples could be highly contaminated by bacteria resistant to commonly used antibiotics and susceptibility profiles easily allow the selection of new antibiotics to incorporate into media. Moreover, because we observed a variability of susceptibility in the strains tested in this study, this variability could be used to select for one genus or species during isolation protocols.
In conclusion, the data presented indicate that the phylum Planctomycetes is composed of broad-spectrum antibiotic-resistant organisms. While the Planctomycetes organisms are naturally resistant to some antibiotic families, we observed large differences in the resistance profiles among genera and species, indicating that the systematic study of antibiotic families performed in the present study was warranted. We recommend the Etest for the accurate determination of antibiotic MICs for Planctomycetes organisms. The precise determination of the antibiotic susceptibility/resistance profile sheds new light on the biology of these organisms, and may help in the rational design of media for the primary isolation and culture of Planctomycetes organisms. Planctomycetes, being harmless organisms, may be used as model organisms to decrypt the molecular bases of antibiotic resistance in PVC organisms at large.
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